Heidi Raises $340M in Funding

Heidi, a New York-based developer of an AI-powered care partner platform for clinicians, has secured $340 million in new funding. The capital includes a $100 million Series C equity round and a $240 million growth investment, bringing the company's total valuation to $900 million. Heidi provides AI-driven documentation, clinical knowledge support, and administrative automation tools to healthcare systems globally.

Investors

The Series C equity round was led by Blackbird, with participation from Phoenix Court (LocalGlobe, Latitude, and Solar funds), Point72 Private Investments, and Headline. The $240 million growth investment was led by General Catalyst’s Customer Value Fund.

Heidi Use of Funds

Heidi plans to use the new capital to deepen adoption within global health systems, expand its agentic capabilities beyond documentation into supervised clinical action, and build out the regulatory and clinical safety foundations required for these advanced features.

About Heidi

Founded in 2021, Heidi provides an AI Care Partner that supports clinicians across the entire working day. The platform assists with administrative tasks and clinical knowledge, aiming to expand global healthcare capacity by reducing burnout and allowing clinicians to focus more on direct patient care.

Funding Details

Company Website: https://heidihealth.com

Company: Heidi
Raised: $340M
Round: Series C
Funding Date: September 22, 2026
Lead Investor: Blackbird, General Catalyst (Customer Value Fund)
Additional Investors: Phoenix Court (LocalGlobe, Latitude, and Solar funds), Point72 Private Investments, Headline
Software Category: Health Technology
Source: https://www.businesswire.com/news/home/20260922400970/en/Heidi-Secures-US%24340M-to-Scale-Agents-Across-Health-Systems-Globally